MedTrace Logo

Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy

NCT01432496 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2013-02-25

No results posted yet for this study

Summary

The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg produces better postoperative pain control than Saline nebulization after laparoscopic colectomy.

Conditions

  • Postoperative Pain

Interventions

DRUG

Ropivacaine 150 mg

Nebulization of Ropivacaine 150 mg in the peritoneal cavity

DRUG

saline 15 ml

Nebulization of saline 15 ml in the peritoneal cavity

Sponsors & Collaborators

  • University of Milano Bicocca

    collaborator OTHER

  • Azienda Ospedaliera di Lecco

    collaborator OTHER

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    collaborator OTHER

  • University of Pavia

    collaborator OTHER

  • San Gerardo Hospital

    lead OTHER

Principal Investigators

  • Pablo M Ingelmo, MD · San Gerardo Hospital, MB, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01432496 on ClinicalTrials.gov